Entrada Therapeutics, Inc. (TRDA) stock
TRDANasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.96−0.04 (-0.80%)
Close on Nov 17, 2026Market cap $193.13MP/E –Yield –
Entrada Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Entrada Therapeutics's market cap was $211.82M on Nov 11, 2026, against $392.51M a year earlier. Over the last 5 years it ranged from $17.13M to $743.90M, with a median of $400.28M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $211.82M | -46.1% |
| 2025 | Dec 31, 2025 | $392.89M | -39.2% |
| 2024 | Dec 31, 2024 | $646.65M | +28.5% |
| 2023 | Dec 29, 2023 | $503.10M | +18.8% |
| 2022 | Dec 30, 2022 | $423.52M | +1498.3% |
| 2021 | Dec 31, 2021 | $26.50M | – |
See a number that looks wrong?